ReviewJournal of blood medicine2018

Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia.

Natalie Uy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.